Volume 4; Issue 2

European Urology Supplements

Volume 4; Issue 2

1

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

Claude C. Schulman, Ragnar Asplund, François Desgrandchamps, Udo Jonas

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 254 KB

english, 2005

2

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Phase 2b Dose-Response Study

Christopher R. Chapple, Jerzy Lorenz, Raymond Mortensen, Harald Pauthner, Mario O. Reis, Claude C. Schulman, Ingrid van der Putten-Slob

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 223 KB

english, 2005

3

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Placebo and Active Comparator Controlled Phase 3a Study

Christopher R. Chapple, Salman H. Al-Shukri, Bernard Gattegno, Simon Holmes, José M. Martínez-Sagarra, Roberto M. Scarpa, Oncko B. van Vierssen Trip, Viktor Vik, Ingrid van der Putten-Slob

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 312 KB

english, 2005

4

The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS®)

Martin C. Michel, Cees Korstanje, Walter Krauwinkel, Mirjam Kuipers

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 303 KB

english, 2005

5

Cardiovascular Safety of Tamsulosin Modified Release in the Fasted and Fed State in Elderly Healthy Subjects

Martin C. Michel, Cees Korstanje, Walter Krauwinkel

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 302 KB

english, 2005

6

Comparison of Vascular α1-Adrenoceptor Antagonism of Tamsulosin in Oral Controlled Absorption System (OCAS) and Modified Release (MR) Formulations

Martin C. Michel, Cees Korstanje, Walter Krauwinkel, Michael Shear, Jonathan Davies, Adrian Quartel

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 305 KB

english, 2005

7

Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation

Martin C. Michel, Cees Korstanje, Walter Krauwinkel, Michael Shear, Jonathan Davies, Adrian Quartel

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

8

The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study

Bob Djavan, Shirin Milani, Jonathan Davies, John Bolodeoku

Journal:

European Urology Supplements

Year:

2005

Language:

english

File:

PDF, 270 KB

english, 2005

9

Editorial Board

Journal:

European Urology Supplements

Year:

2005

File:

PDF, 29 KB

2005

10

Subject Index

Journal:

European Urology Supplements

Year:

2005

File:

PDF, 26 KB

2005